Recent Articles

September 11, 2014 2:41 pm
Cynthia Fox, Science Editor
One of the most rapidly fast-tracked vaccines in history— an anti-Ebola “ChAd3” vaccine— just started clinical trial in humans, and may be done as soon as November. But a second fast-tracked anti-Ebola vaccine— called an “rVSV” vaccine— is hot on its heels. Read more...
September 9, 2014 9:30 am
Dr. Kenneth James, Supercritical Fluid Technologies, Inc.
The need for pharmaceutical grade cannabis oil has increased as researchers continue to investigate its use for the treatment of various ailments such as muscle spasms, glaucoma, nausea, mood and behavioral disorders, sleep disorders and chronic pain. Read more...
September 4, 2014 10:36 am
Matthew Weinberg, CEO, The Weinberg Group
Outsourcing is an old concept in the healthcare industry that has recently been applied to a new area: regulatory affairs. Traditionally conducted in-house, regulatory affairs is extremely critical to a product’s success. For certain companies, this entire function can and should be outsourced in its entirety, not just for discrete projects.
September 3, 2014 10:15 am
Cynthia Fox, Science Editor
ZMapp, the experimental drug that may have already have saved a few patients in Africa, is the most effective anti-Ebola therapy yet, according to a recent Nature paper on rhesus macaques monkeys. Read more...           
Subscribe to Drug Discovery & Development